# Diagnostic Immunization With Rabies Vaccine in Patients With PID

> **NCT02490956** · PHASE4 · UNKNOWN · sponsor: **Chulalongkorn University** · enrollment: 40 (estimated)

## Conditions studied

- Primary Immunodeficiency

## Interventions

- **BIOLOGICAL:** Verorab® (PVRV; Purified Vero Cell Vaccine)

## Key facts

- **NCT ID:** NCT02490956
- **Lead sponsor:** Chulalongkorn University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-04
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2015-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02490956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02490956, "Diagnostic Immunization With Rabies Vaccine in Patients With PID". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02490956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*